Ov D Slayden

University of Missouri-Columbia

NIH Rank #7880
  • Program Leader
  • R01 Holder
  • Translational
  • Multi-Institutional
  • Early Career

NIH Funding · FY2024

Total Funding
$1.6M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#7,880
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.6M across 4 grants · National rank #7880.

Top grants by award amount

Ov D Slayden's NIH grant portfolio, ranked by award amount.

  • 5R01HD108198-04R01
    Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
    $691.6K
    award amount
  • 5R01HD101450-04R01
    Development of magnetic hyperthermia for the systemic treatment of endometriosis
    $658.1K
    award amount
  • 5P01HD106485-04P01
    Collaborative Center to Develop Improved Diagnostic and Therapeutic Approaches to Endometriosis
    $170.1K
    award amount
  • 3R01HD108198-04S1R01
    Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
    $69.8K
    award amount

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of Missouri-Columbia
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #7880
  5. 2024
    Multi-Institutional Research
    Awards at 3 institutions